Related Experiment Videos
Neonatal platelet function: a membrane-related phenomenon?
Insights
Neonatal platelets demonstrate fully developed prostaglandin endoperoxide synthesis. However, defective secondary aggregation and release in neonates stem from impaired arachidonic acid release, not nucleotide storage issues.
Area of Science:
- Biochemistry
- Neonatal Physiology
- Platelet Biology
Background:
- Platelet function and prostaglandin synthesis are crucial in neonatal hemostasis.
- Understanding neonatal platelet response to stimuli is vital for assessing bleeding risks.
Purpose of the Study:
- To evaluate prostaglandin endoperoxide synthesis in maternal and neonatal platelets.
- To investigate the cause of defective secondary aggregation and ADP release in neonatal platelets.
Main Methods:
- Incubation of maternal and neonatal platelets with 1-14C-arachidonic acid (AA).
- Analysis of prostaglandin metabolites using thin layer radiochromatography.
- Radioimmunoassay for thromboxane B2 (TXB2) in platelet-rich plasma (PRP).
- Assessment of platelet aggregation and ADP release in mixed neonatal and aspirin-treated adult PRP.
Main Results:
- Maternal and neonatal platelets showed normal aggregation in response to AA.
- Similar incorporation of radioactivity into HHT and TXB2 by maternal and neonatal platelets.
- No significant differences in TXB2 levels between maternal and neonatal platelets.
- Mutual correction of aggregation and release defects when neonatal platelets were mixed with aspirin-treated adult platelets.
Conclusions:
- Prostaglandin endoperoxide synthesis is fully developed in neonatal platelets.
- Neonatal platelets possess normal storage pool nucleotides.
- Defective secondary aggregation and release in neonatal platelets are attributed to a failure in arachidonic acid release from membrane phospholipids.
Abstract:
Synthesis of prostaglandin endoperoxides was evaluated in paired maternal and cord blood samples. Platelets from mothers and neonates aggregated normally in response to arachidonic acid (AA). Cyclooxygenase activity was evaluated by monitoring the incorporation of radioactivity into prostaglandin endoperoxide metabolites after incubation with 1-14C-AA. Thin layer radiochromatograms of methylated incubation products revealed three main peaks corresponding to 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid, 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT), and 8-(1-hydroxy-3-oxoproply)-9,12-L-dihydroxy-5,10-heptadecadienoic acid (TXB2). Maternal and neonatal platelets incorporated similar amounts of radioactivity into HHT and TXB2. Radioimmunoassay for TXB2 in thrombin-clotted PRP revealed no significant differences between maternal and neonatal platelets. Since these metabolites are derived from cyclic endoperoxides formed by the action of cyclooxygenase on AA, we conclude that prostaglandin endoperoxide synthesis is fully developed in neonatal platelets. Mutual correction of collagen-induced platelet aggregation and ADP release was observed when equal volumes of neonatal and aspirin-treated adult platelet-rich plasma were mixed. Therefore, since neonatal platelets contain normal amounts of storage pool nucleotides, we also conclude that the defective secondary aggregation and release seen in neonatal platelets is caused by a failure in the release of AA from membrane phospholipids upon stimulation with collagen or epinephrine.